Reduced risk of new-onset diabetes with trandolapril/verapamil-SR in patients with the metabolic syndrome.
D000959:Antihypertensive Agents / Q000008:administration & dosage*; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D024821:Metabolic Syndrome / Q000453:epidemiology*; D014700:Verapamil / Q000494:pharmacology*
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D007211:Indoles; C052035:trandolapril; D014700:Verapamil